Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Pedro Rosa‐Neto, Marie Vermeiren et al.|JAMA Neurology|2022Cited by 261
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa A. Sperling, Gary Romano, David Henley et al.|JAMA Neurology|2021Cited by 110
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Oskar Hansson, Andrew J. Aschenbrenner et al.|Brain|2024Cited by 95
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrumJaime Fernández Arias, Pedro Rosa‐Neto, Wagner S. Brum et al.|Brain|2025Cited by 22
Novel avenues of tau researchClaire E. Sexton, María C. Carrillo, Gal Bitan et al.|Alzheimer s & Dementia|2024Cited by 17